Wockhardt Posts Reduced Quarterly Loss Amid Revenue Growth

Wockhardt, a Mumbai-based drug firm, reported a reduced consolidated net loss of Rs 16 crore for the first quarter ending June 2024, compared to Rs 136 crore in the same quarter last year. Total income for the period increased to Rs 769 crore, up from Rs 658 crore a year ago. Shares ended 3.99% higher at Rs 955.90 on the BSE.

Drug firm Wockhardt on Friday reported a consolidated net loss of Rs 16 crore for the first quarter ended June 30, 2024.

This marks a significant improvement from the Mumbai-based company's net loss of Rs 136 crore in the comparable quarter of the previous fiscal year.

Total income for the first quarter rose to Rs 769 crore in contrast to Rs 658 crore in the same period last year, according to a regulatory filing by the drug maker.

Shares of Wockhardt closed 3.99 percent higher at Rs 955.90 apiece on the BSE on Friday.